DIN 02545721 — XENPOZYME 20 MG
XENPOZYME is a powder for solution of Olipudase alfa marketed by SANOFI-AVENTIS CANADA INC. The full Olipudase alfa monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02545721
- Brand name
- XENPOZYME
- Active ingredient
- Olipudase alfa
- Strength
- 20 MG
- Dosage form
- POWDER FOR SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- SANOFI-AVENTIS CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Enzyme replacement therapy (recombinant human acid sphingomyelinase)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.